Linagliptin controls glucose in most KT recipients with PTDM | ESOT

Of fasting and non-fasting glucose in the treated group, 99.5% were <11.1 and 80.7% were <7.
Of fasting and non-fasting glucose in the treated group, 99.5% were <11.1 and 80.7% were <7.